Almost all CCS skin tumours exhibit loss of heterozygosity affecting chromosome 16q12-13, the CYLD locus (Blake and Toro, 2009; Davies et al., 2019; Leonard et al., 2001). This evidence concerns the gene CYLD and skin neoplasm.